Rawan Alanazi

Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

Mohammed J. F. Alenazi, H. Balkhy, S. Gilbert, 2021, The Lancet Microbe.

KNOWLEDGE, ATTITUDE AND PRACTICE OF ORAL HYGIENE AMONG NURSING STAFF IN PEDIATRIC CARE HOSPITALS IN RIYADH, SAUDI ARABIA

S. Khanagar, H. Alotiabi, M. Almousa, 2020 .